Live Analyst Rating Changes 35903 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Luke Sergott
BARC

Luke Sergott

Barclays
Wall Street Analyst
★★★★★
#43
on 13Foresight · ranked by our own returns
76%
Success Rate
+9.9%
Average Return
68 of 90 calls profitable · +8.0% vs benchmark
S&P 500 (SPY)
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 76% of Luke Sergott's ratings turned a profit when each position was held for 1 year — averaging +9.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

154 Buy 64 Hold 24 Sell
Luke's Stock Coverage 28 ratings · 2026-09-30
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
NTRA
Natera
 Sep 25, 2026 BUY Strong Buy
-22.6% avg upside
28 analysts
$340.00
17.92% Downside
 -0.5% ·
CRL
Charles River Labs
 Sep 24, 2026 BUY Strong Buy
-14.9% avg upside
35 analysts
$330.00
11.54% Upside
 -0.5% ·
DGX
Quest Diagnostics
 Sep 23, 2026 BUY Strong Buy
-20.8% avg upside
34 analysts
$250.00
7.84% Upside
 +1.7% ·
GH
Guardant Health
 Sep 18, 2026 BUY Strong Buy
-5.6% avg upside
32 analysts
$200.00
12.57% Upside
 -0.8% ·
LH
Labcorp Holdings
 Sep 11, 2026 HOLD Strong Buy
-13.0% avg upside
37 analysts
$330.00
6.83% Upside
 -0.6% ·
FTRE
Fortrea Holdings Inc.
 Sep 03, 2026 HOLD Buy
+3.4% avg upside
12 analysts
$22.00
11.38% Upside
 +6.8% ·
A
Agilent
 Aug 27, 2026 BUY Strong Buy
-9.7% avg upside
34 analysts
$175.00
0.08% Upside
 +9.6% ·
BRKR
Bruker
 Aug 25, 2026 BUY Buy
-8.7% avg upside
22 analysts
$58.00
10.09% Downside
 +11.4% ·
QGEN
Qiagen
 Aug 07, 2026 HOLD Buy
-2.9% avg upside
24 analysts
$40.00
9.93% Downside
 +4.2% ·
SHC
Sotera Health
 Aug 07, 2026 BUY Strong Buy
+17.5% avg upside
13 analysts
$22.00
18.20% Upside
 -2.2% ·
TXG
10x Genomics
 Aug 06, 2026 BUY Buy
-39.8% avg upside
19 analysts
$52.00
42.33% Downside
 +97.5% ·
PACB
Pacific Biosciences
 Aug 05, 2026 SELL Buy
+149.4% avg upside
14 analysts
$1.25
31.63% Downside
 -40.8% ·
WAT
Waters
 Aug 05, 2026 BUY Strong Buy
-9.8% avg upside
31 analysts
$460.00
3.79% Upside
 +8.4% ·
CERT
Certara
 Aug 05, 2026 HOLD Buy
+41.8% avg upside
22 analysts
$7.50
18.97% Downside
 +7.9% ·
RVTY
Revvity
 Aug 04, 2026 HOLD Buy
-24.6% avg upside
23 analysts
$115.00
24.67% Downside
 +35.3% ·
DHR
Danaher
 Aug 04, 2026 BUY Strong Buy
-6.0% avg upside
47 analysts
$230.00
1.75% Upside
 +15.9% ·
TWST
Twist Bioscience
 Aug 03, 2026 BUY Strong Buy
-50.0% avg upside
15 analysts
$112.00
39.79% Downside
 +84.2% ·
MTD
Mettler-Toledo
 Aug 03, 2026 BUY Buy
-19.8% avg upside
19 analysts
$1575.00
2.49% Upside
 +5.1% ·
ILMN
Illumina
 Jul 31, 2026 SELL Buy
-31.7% avg upside
31 analysts
$160.00
41.16% Downside
 -32.6% ·
IQV
IQVIA Holdings
 Jul 29, 2026 BUY Strong Buy
-7.4% avg upside
39 analysts
$275.00
2.15% Upside
 +8.4% ·
AVTR
Avantor
 Jul 29, 2026 SELL Buy
+3.7% avg upside
26 analysts
$13.00
14.68% Downside
 -5.7% ·
RGEN
Repligen
 Jul 28, 2026 BUY Strong Buy
-11.6% avg upside
25 analysts
$175.00
9.99% Downside
 +30.5% ·
WST
West Pharmaceutical Services
 Jul 24, 2026 BUY Strong Buy
-2.2% avg upside
18 analysts
$400.00
6.12% Upside
 +14.5% ·
TMO
Thermo Fisher
 Jul 24, 2026 BUY Strong Buy
-9.4% avg upside
40 analysts
$650.00
4.32% Downside
 +19.5% ·
MEDP
Medpace Holdings
 Jul 23, 2026 HOLD Hold
-22.9% avg upside
17 analysts
$450.00
27.71% Downside
 +2.2% ·
ICLR
Icon
 Jun 24, 2026 HOLD Strong Buy
+8.9% avg upside
26 analysts
$175.00
2.75% Upside
 +7.7% ·
LUMN
Lumen Technologies
 Jun 12, 2023 HOLD Hold
+93.8% avg upside
21 analysts
$42.00
658.03% Upside
 -32.8% ·
JBHT
JB Hunt
 Jan 18, 2023 BUY Strong Buy
+16.5% avg upside
33 analysts
$200.00
12.77% Downside
 +7.4% ·
🔒 23 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Luke Sergott — Frequently Asked Questions
How accurate are Luke Sergott's stock ratings?
Based on the calls 13Foresight could measure, about 76% of Luke's ratings were profitable over a one-year hold, with an average return of +9.9% per rating, or +8.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Luke ranked on 13Foresight?
Luke Sergott is currently ranked #43 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Luke cover?
Luke most recently has ratings on NTRA, CRL, DGX, GH, LH, FTRE, A, BRKR, QGEN, SHC, TXG, PACB and 16 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.